GlycoMimetics appoints Scott Koenig to board
Dr. Koenig has been President, CEO and a director of MacroGenics since 2001 and was one of the company’s founders.
Previously, Dr. Koenig was Senior Vice President of Research at MedImmune, participating in the selection and maturation of the company’s product pipeline.
Before that, he worked in the National Institute of Allergy and Infectious Diseases’ Laboratory of Immunoregulation.
In addition to serving as Chair of the Applied Genetic Technologies Corporation, Dr. Koenig also serves as a member of the Board of Directors of the Biotechnology Innovation Organization (BIO) and the International Biomedical Research Alliance, and co-chairs the Scientific Advisory Board of the Institute for Bioscience and Biotechnology Research (IBBR) at the University of Maryland.
Previously, Dr. Koenig served as a member of the Scientific Management Review Board at the NIH, and of the Board of Directors of Children’s National Health System, where he was also the Chairman of the Board of the Children’s Research Institute.
Dr. Koenig received his M.D. from the University of Texas Health Science Center in Houston, and his Ph.D. and A.B. from Cornell University. ■
LATEST MOVES FROM Maryland
- Marriott International appoints Rena Reiss as executive vice president
- Eagle Bancorp appoints Susan G. Riel to board
- Colfax Corporation appoints Didier Teirlinck to board
- Lockheed Martin appoints Stephanie C. Hill as vice president
- Global Medical REIT president Jeffrey Busch to take CEO role
More inside POST
How do you know you have great employees? Leadership
The most important 'no' in your career Leadership